105 related articles for article (PubMed ID: 32714681)
1. Diffuse Alveolar Hemorrhage Secondary to Ibrutinib Therapy in a Patient With Refractory Mantle Cell Lymphoma.
Locke CB; Lansigan F
Cureus; 2020 Jun; 12(6):e8743. PubMed ID: 32714681
[TBL] [Abstract][Full Text] [Related]
2. Management of Atrial Fibrillation in Patients on Ibrutinib: A Cleveland Clinic Experience.
Khalid S; Yasar S; Khalid A; Spiro TP; Haddad A; Daw H
Cureus; 2018 May; 10(5):e2701. PubMed ID: 30062075
[TBL] [Abstract][Full Text] [Related]
3. Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma.
Owen C; Berinstein NL; Christofides A; Sehn LH
Curr Oncol; 2019 Apr; 26(2):e233-e240. PubMed ID: 31043832
[TBL] [Abstract][Full Text] [Related]
4. Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature.
Damaraju V; Agarwal R; Singh Sehgal I; Khadwal A; Bal A; Rudramurthy SM; Muthu V
J Mycol Med; 2023 Aug; 33(3):101414. PubMed ID: 37523991
[TBL] [Abstract][Full Text] [Related]
5. Ibrutinib Treatment through Nasogastric Tube in a Comatose Patient with Central Nervous System Localization of Mantle Cell Lymphoma.
Alsuliman T; Belghoul M; Choufi B
Case Rep Hematol; 2018; 2018():5761627. PubMed ID: 30186643
[TBL] [Abstract][Full Text] [Related]
6. Life-threatening disseminated enterovirus infection during combined rituximab and ibrutinib maintenance treatment for mantle cell lymphoma: a case report.
Higer M; Cana D; Podlech J; Schadmand-Fischer S; Schwarting A; Teschner D; Theobald M; Wölfel T; Hess G
J Med Case Rep; 2020 Aug; 14(1):135. PubMed ID: 32859260
[TBL] [Abstract][Full Text] [Related]
7. Reversible Systolic Heart Failure in a Patient on Ibrutinib Chemotherapy.
Khaja M; Gurjar H; Yapor L; Abraham MC; Hernandez N; Haider A
Cureus; 2022 Mar; 14(3):e23266. PubMed ID: 35449638
[TBL] [Abstract][Full Text] [Related]
8. New and emerging Bruton tyrosine kinase inhibitors for treating mantle cell lymphoma - where do they fit in?
Rule S; Chen RW
Expert Rev Hematol; 2018 Sep; 11(9):749-756. PubMed ID: 30052472
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of ibrutinib-associated central nervous system hemorrhage with platelet transfusion support.
Seiter K; Stiefel MF; Barrientos J; Shaikh A; Ahmed N; Baskind P; Liu D
Stem Cell Investig; 2016; 3():27. PubMed ID: 27583253
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: observation to transplantation.
Rajabi B; Sweetenham JW
Ther Adv Hematol; 2015 Feb; 6(1):37-48. PubMed ID: 25642314
[TBL] [Abstract][Full Text] [Related]
11. [Treatment for mantle cell lymphoma].
Izutsu K
Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
[TBL] [Abstract][Full Text] [Related]
12. Ibrutinib Treatment of Mantle Cell Lymphoma Relapsing at Central Nervous System: A Case Report and Literature Review.
Mannina D; Loteta B
Case Rep Hematol; 2017; 2017():9583257. PubMed ID: 28791187
[TBL] [Abstract][Full Text] [Related]
13. [Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches].
Klener P; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
[TBL] [Abstract][Full Text] [Related]
14. Bruton tyrosine kinase inhibitor ONO/GS-4059: from bench to bedside.
Wu J; Zhang M; Liu D
Oncotarget; 2017 Jan; 8(4):7201-7207. PubMed ID: 27776353
[TBL] [Abstract][Full Text] [Related]
15. A case of new-onset cardiomyopathy and ventricular tachycardia in a patient receiving ibrutinib for relapsed mantle cell lymphoma.
Wallace N; Wong E; Cooper D; Chao H
Clin Case Rep; 2016 Dec; 4(12):1120-1121. PubMed ID: 27980745
[TBL] [Abstract][Full Text] [Related]
16. Paronychia and Periungual Granulation as a Novel Side Effect of Ibrutinib: A Case Report.
Yorulmaz A; Yalcin B
Skin Appendage Disord; 2020 Jan; 6(1):32-36. PubMed ID: 32021859
[TBL] [Abstract][Full Text] [Related]
17. Ibrutinib Caused Mediastinal Emphysema and Pneumothorax in the Treatment of a Patient with Mantle Cell Lymphoma.
Tsutsumi Y; Sekine T; Ito S; Matsuoka S; Teshima T
Drug Saf Case Rep; 2019 Feb; 6(1):3. PubMed ID: 30790080
[TBL] [Abstract][Full Text] [Related]
18. Ibrutinib-Induced Paronychia and Periungual Pyogenic Granuloma.
Alamri A; Alghamdi Y; Alghamdi A; Albogami DB; Shahada O; AlHarbi A
Cureus; 2022 Dec; 14(12):e32943. PubMed ID: 36712781
[TBL] [Abstract][Full Text] [Related]
19. NF-κB signaling and its relevance to the treatment of mantle cell lymphoma.
Balaji S; Ahmed M; Lorence E; Yan F; Nomie K; Wang M
J Hematol Oncol; 2018 Jun; 11(1):83. PubMed ID: 29907126
[TBL] [Abstract][Full Text] [Related]
20. Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib.
Sun K; Kasparian S; Iyer S; Pingali SR
Ecancermedicalscience; 2018; 12():836. PubMed ID: 29910833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
